Cargando…
Pentosan polysulfate induces low-level persistent prion infection keeping measurable seeding activity without PrP-res detection in Fukuoka-1 infected cell cultures
Each prion strain has its own characteristics and the efficacy of anti-prion drugs varies. Screening of prion disease therapeutics is typically evaluated by measuring amounts of protease-resistant prion protein (PrP-res). However, it remains unclear whether such measurements correlate with seeding a...
Autores principales: | Takatsuki, Hanae, Imamura, Morikazu, Mori, Tsuyoshi, Atarashi, Ryuichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106670/ https://www.ncbi.nlm.nih.gov/pubmed/35562591 http://dx.doi.org/10.1038/s41598-022-12049-z |
Ejemplares similares
-
Central residues in prion protein PrP(C) are crucial for its conversion into the pathogenic isoform
por: Pasiana, Agriani Dini, et al.
Publicado: (2022) -
Maculopathy caused by pentosan polysulfate
por: Rosenberg, Daniel, et al.
Publicado: (2021) -
Comparison of the Anti-Prion Mechanism of Four Different Anti-Prion Compounds, Anti-PrP Monoclonal Antibody 44B1, Pentosan Polysulfate, Chlorpromazine, and U18666A, in Prion-Infected Mouse Neuroblastoma Cells
por: Yamasaki, Takeshi, et al.
Publicado: (2014) -
Ethanolamine Is a New Anti-Prion Compound
por: Uchiyama, Keiji, et al.
Publicado: (2021) -
Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses
por: Schuchman, Edward H., et al.
Publicado: (2013)